
    
      The evidence generated by this study is expected to help inform medical decision makers with
      the clinical and economic data of therapy for AF patients, and also provide policy decision
      makers with information that can be considered /used to allocate funds for AF ablation and
      permit patients to have access to appropriate treatment options for AF management.
    
  